国内唯一获批干细胞药物首位患者出院,阿里健康加速商业化落地

健识局
Sep 15, 2025

9月14日,央视新闻频道报道了一则干细胞领域的重磅新闻——国内首位接受艾米迈托赛注射液治疗的患者病情好转,已经获准出院。据央视新闻频道报道,该患者为一名青年女性,在北京大学人民医院接受造血干细胞移植后出现了重度肠道急性移植物抗宿主病,经多项治疗均无明显获益,一度生命垂危。今年6月,医生为其开出了艾米迈托赛注射液首张处方。经过治疗,该患者病情好转,已经获准出院,后续只需定期服药和复查即可。艾米迈托赛...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10